turnover (SET and mai) for 3Q18 decreased from Baht 59,853 million in 2Q18 to Baht 53,343 million, a 10.9% decreased. The SET index at the end of 3Q18 closed at 1,756.41 points, increasing by 10.1% from

-patients department inclined by 24.6% and 8.9% respectively. Causing the increasing in the total revenue from Gastrointestinal diseases and seasonal diceases such as Nasopharyngitis, Influenza, Dengue Fever

%. Costs of hospital operations incurred with total revenues from medical treatment for the Year 2018, equaled to 68.8% comparing to the Year 2017, equaled to 71.7%. Causing from the increasing of overtime

2017, equaled to 71.5%. Causing from the increasing of overtime pay and doctor fee. Selling Expenses The selling expenses for the 2nd quarter of Year 2017 and 2018 were in amounts of Baht 3.16 million

2017, equaled to 74.6%. Causing from the increasing of overtime pay and doctor fee. Selling Expenses The selling expenses for the 3rd quarter of Year 2017 and 2018 were in amounts of Baht 2.88 million

of AEON Thana Sinsap (Thailand) Plc. No. 3/2018 held on March 20, 2018 had a resolution of the connected transaction as follows: Date of agreement: Company Date of agreement ACS Capital Corporation

meeting of AEON Thana Sinsap (Thailand) Plc. No. 03/2020 held on March 10, 2020 had a resolution of the connected transaction as follows: Date of agreement: Company Date of agreement ACS Capital Corporation

length of stay. Furthermore, there have been an increasing numbers of suggestions towards OPD treatments. However, the revenue of OPD increased by 12.2% comparing to the same period last year due to the

, increasing 20% YoY from TTTBB consolidation and organic business growth, while increasing 1.4% QoQ driven by continued demand for mobile and fixed broadband connectivity. FBB maintained a growth engine

current investment. 2. Cost of sale , Profit margin For year 2018, the company had cost of sale of 396.52 million bath compare to 333.48 million baht last year with the increasing of 63.04 million bath or